CDSCO Drug Alert: 48 drug samples flagged not of standard quality - Video

Published On 2023-04-27T15:09:09+05:30 | Updated On 27 April 2023 3:09 PM IST

Overview

In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 48 medicine batches for failing to qualify random drug sample test for the month of March-2023.

These drugs samples include Telmisartan Tablets manufactured by Ridley Life Sciences, Domperidone Tablets manufactured by Karnataka Antibiotics & Pharmaceuticals, Pioglitazone Hydrochloride Tablets manufactured by Skymap Pharmaceutical, Domperidone Tablets manufactured by Rivpra Formulation, Gabapentin Tablets manufactured by Synokem Pharmaceuticals and Mascot Health Series, Rolled Bandage (Non Sterilized, Size 15cm x 4 mts manufactured by Disha Surgicals, Dactinomycin for Injection USP 0.5 mg by Celon Laboratories, Iron and Folic Acid Tablets I.P. manufactured by Nestor Pharmaceuticals and others.

For more details, check out the link given below:

CDSCO Drug Alert: 48 Drug Samples Flagged Not Of Standard Quality

Speakers

Isra Zaman

B.Sc Life Sciences, M.Sc Biotechnology, B.Ed

Isra Zaman is a Life Science graduate from Daulat Ram College, Delhi University, and a postgraduate in Biotechnology from Amity University. She has a flair for writing, and her roles at Medicaldialogues include that of a Sr. content writer and a medical correspondent. Her news pieces cover recent discoveries and updates from the health and medicine sector. She can be reached at editorial@medicaldialogues.in.